摘要
对1991~1995年的各类西药以购入金额进行了排名及动态变化分析.1995年,抗微生物药、生物和生化药物、免疫系统药物等位居前十位,这种结构与国内同等规模的医院相似,但与世界药品结构差别较大;5年中它们的购入金额占西药总购入金额的90~94%,其中抗微生物药的排名一直居于首位,生物和生化药物的排名一直位居第二,免疫系统药物的变化最大,以年均284.93%的速度增长,排名由1991年的第13位升至1995年的第3位,其它各类的排名有升有降.5年中有数十种疗效好的新药进入临床使用,填补了一些空白或替代了老品种,但不合理用药的现象仍然存在.
Use of drugs in our hospital from 1991 to 1995 was statistically analyzed. Antimicroor-ganism drugs, biological-biochemical drugs and immune system drugs etc. were on the top of the list. The pattern was similar to the those of hospitals of same size in China, but there was still a substantial difference as compared with the pattern of world drug structure. These money spent for the 10 major drugs consisted of 90% to 94% of total budget for western drugs over a period of 5 years, with the anti-microorganism drugs being on the very top, followed by biological-biochemical drugs. Immune system drugs varied greatly.: They increased by 284. 93% each year with their place in the list going up from the thirteen in 1991 to the third in 1995. Some effective new drugs were put into clinical use, filling some blank or replace some old drugs. The unreasonable use of drugs still exists.
出处
《药物流行病学杂志》
CAS
1998年第1期30-33,共4页
Chinese Journal of Pharmacoepidemiology